Yusuke Suzuki

No ORCID on file · 2 papers in corpus

rct 2022

Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study

Fertility and sterility ·doi:10.1016/j.fertnstert.2021.11.013

OBJECTIVE: To evaluate the efficacy and safety of 40-mg relugolix (REL) compared with those of leuprorelin (LEU) in women with endometriosis-associated pain. DESIGN: Phase 3, multicenter, randomized, double-blind, double-dummy, active-cont…

lab-animal 2018

Establishment of a novel mouse xenograft model of human uterine leiomyoma

Scientific reports ·doi:10.1038/s41598-018-27138-1

Uterine leiomyoma is the most common benign tumour in women, and an appropriate animal model for leiomyoma would be useful for exploring new therapeutic strategies. Therefore, we have been challenged to develop a new simple mouse model for …